Last update 08 May 2025

APL-4098

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
APL 4098, APL4098
Target-
Action
inhibitors
Mechanism
kinase inhibitor
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
Acute Myeloid Leukemia with Myelodysplasia-Related ChangesHigh Risk Myelodysplastic SyndromeRelapsing acute myeloid leukemia
Inactive Indication-
Originator Organization
Apollo TherapeuticsApollo Therapeutics
Active Organization
Apollo TherapeuticsApollo Therapeutics
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with APL-4098
NCT06372717
/ RecruitingPhase 1/2
A Phase 1/2 Study to Assess the Safety and Antitumor Activity of APL-4098 Alone and/or in Combination With Azacitidine in Adults With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome/AML (MDS/AML) or Myelodysplastic Syndrome With Excess Blasts (MDS-EB)
100 Clinical Results associated with APL-4098
Login to view more data
100 Translational Medicine associated with APL-4098
Login to view more data
100 Patents (Medical) associated with APL-4098
Login to view more data
100 Deals associated with APL-4098
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid Leukemia with Myelodysplasia-Related ChangesPhase 2
Australia
Apollo TherapeuticsApollo Therapeutics
04 Jun 2024
Acute Myeloid Leukemia with Myelodysplasia-Related ChangesPhase 2
United Kingdom
Apollo TherapeuticsApollo Therapeutics
04 Jun 2024
High Risk Myelodysplastic SyndromePhase 2
Australia
Apollo TherapeuticsApollo Therapeutics
04 Jun 2024
High Risk Myelodysplastic SyndromePhase 2
United Kingdom
Apollo TherapeuticsApollo Therapeutics
04 Jun 2024
Relapsing acute myeloid leukemiaPhase 2
Australia
Apollo TherapeuticsApollo Therapeutics
04 Jun 2024
Relapsing acute myeloid leukemiaPhase 2
United Kingdom
Apollo TherapeuticsApollo Therapeutics
04 Jun 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free